NeuroMetrix (NURO) Scheduled to Post Quarterly Earnings on Tuesday

NeuroMetrix (NASDAQ:NURO) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 6th.

NeuroMetrix (NASDAQ:NURO) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. The company had revenue of $1.09 million during the quarter. NeuroMetrix had a negative return on equity of 39.85% and a negative net margin of 151.51%.

NeuroMetrix Stock Up 1.4 %

Shares of NeuroMetrix stock opened at $3.59 on Thursday. The firm has a market capitalization of $7.22 million, a P/E ratio of -0.57 and a beta of 2.30. The company has a 50 day moving average price of $3.73 and a 200 day moving average price of $3.75. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $7.59.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of NeuroMetrix in a research note on Wednesday. They set a “sell” rating on the stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.